Significantly higher rates of gastrointestinal bleeding and thromboembolic events with left ventricular assist devices

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 9, 2014, Pages 1461-1467

  Shrode, Charles W ^a   Draper, Karen V ^c   Huang, Robert J ^c   Kennedy, Jamie L W ^a   Godsey, Adam C ^b   Morrison, Christine C ^a   Shami, Vanessa M ^a   Wang, Andrew Y ^a   Kern, John A ^a   Bergin, James D ^a   Ailawadi, Gorav ^a   Banerjee, Dipanjan ^d   Gerson, Lauren B ^d   Sauer, Bryan G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Complication; Heart failure; Hemorrhage; Morbidity; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREVALENCE; THROMBOEMBOLISM; ADVERSE EFFECTS; ANIMAL; HEART ASSIST DEVICE; INCIDENCE; MIDDLE AGED; RAT; RETROSPECTIVE STUDY;

ADULT; AGED; ANIMALS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RATS; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 84906791244     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.01.027     Document Type: Article

References (27)

1. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. NEngl J Med 2001, 345:1435-1443.
2. John R., Kamdar F., Eckman P., et al. Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices. Ann Thorac Surg 2011, 92:1593-1599. discussion 1599-1600.
3. John R., Kamdar F., Liao K., et al. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008, 86:1227-1234. discussion 1234-1225.
4. Aggarwal A., Pant R., Kumar S., et al. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg 2012, 93:1534-1540.
5. Demirozu Z.T., Radovancevic R., Hochman L.F., et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. JHeart Lung Transplant 2011, 30:849-853.
6. Stern D.R., Kazam J., Edwards P., et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. JCard Surg 2010, 25:352-356.
7. John R., Kamdar F., Liao K., et al. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. JThorac Cardiovasc Surg 2008, 136:1318-1323.
8. Slaughter M.S. Hematologic effects of continuous flow left ventricular assist devices. JCardiovasc Transl Res 2010, 3:618-624.
9. Geisen U., Heilmann C., Beyersdorf F., et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008, 33:679-684.
10. Klovaite J., Gustafsson F., Mortensen S.A., et al. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). JAm Coll Cardiol 2009, 53:2162-2167.
11. Meyer A.L., Malehsa D., Bara C., et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010, 3:675-681.
12. Slaughter M.S., Naka Y., John R., et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. JHeart Lung Transplant 2010, 29:616-624.
13. Genovese E.A., Dew M.A., Teuteberg J.J., et al. Early adverse events as predictors of 1-year mortality during mechanical circulatory support. JHeart Lung Transplant 2010, 29:981-988.
14. Godino C., Lauretta L., Pavon A.G., et al. Heyde's syndrome incidence and outcome in patients undergoing transcatheter aortic valve implantation. JAm Coll Cardiol 2013, 61:687-689.
15. King R.M., Pluth J.R., Giuliani E.R. The association of unexplained gastrointestinal bleeding with calcific aortic stenosis. Ann Thorac Surg 1987, 44:514-516.
16. Thompson J.L., Schaff H.V., Dearani J.A., et al. Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome. JThorac Cardiovasc Surg 2012, 144:112-116.
17. Zellner J.L., Kratz J.M., Crumbley A.J., et al. Long-term experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg 1999, 68:1210-1218.
18. Hering D., Piper C., Bergemann R., et al. Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study. Chest 2005, 127:53-59.
19. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. Arch Intern Med 1996, 156:409-416.
20. Ghate S.R., Biskupiak J., Ye X., et al. All-cause and bleeding-related health care costs in warfarin-treated patients with atrial fibrillation. JManag Care Pharm 2011, 17:672-684.
21. Crow S., Chen D., Milano C., et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 2010, 90:1263-1269. discussion 1269.
22. Uriel N., Pak S.W., Jorde U.P., et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. JAm Coll Cardiol 2010, 56:1207-1213.
23. Anderson R.P., McGrath K., Street A. Reversal of aortic stenosis, bleeding gastrointestinal angiodysplasia, and von Willebrand syndrome by aortic valve replacement. Lancet 1996, 347:689-690.
24. Cappell M.S., Lebwohl O. Cessation of recurrent bleeding from gastrointestinal angiodysplasias after aortic valve replacement. Ann Intern Med 1986, 105:54-57.
25. Hollestelle M.J., Loots C.M., Squizzato A., et al. Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients. JThromb Haemost 2011, 9:953-958.
26. Menconi M.J., Pockwinse S., Owen T.A., et al. Properties of blood-contacting surfaces of clinically implanted cardiac assist devices: gene expression, matrix composition, and ultrastructural characterization of cellular linings. JCell Biochem 1995, 57:557-573.
27. Spanier T., Oz M., Levin H., et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. JThorac Cardiovasc Surg 1996, 112:1090-1097.